• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE ACUSEAL VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE ACUSEAL VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT Back to Search Results
Device Problem Microbial Contamination of Device (2303)
Patient Problem Unspecified Infection (1930)
Event Date 05/01/2018
Event Type  Injury  
Manufacturer Narrative
Additional manufacturer narrative: review of the manufacturing records could not be performed as no lot number information was provided.The devices were not returned.Consequently, direct product analysis was not possible.Additional information about these events could not be obtained.As a result, no further investigation is possible.All information has been placed on file for use in tracking and trending.Note: no actual event date was provided.Therefore, date of event is an estimate based on publication date of the article.Note: no actual patient age was provided.Therefore, age at time of event is an estimate based on the average age identified in the article.(b)(4).
 
Event Description
The following information was obtained through literature review: t, abe., et al (may, 2018)."treatment results using gore® acuseal vascular graft." the japanese journal of phlebology.29 (2).261.From april, 2016 to january, 2018, 32 patients underwent arterio-venous shunt procedures using gore® acuseal vascular grafts to treat renal disease.Patient demographics shows that there were 20 males and 12 females with the average age of 66.3 years old.25 patients were implanted with the gore® acuseal vascular graft in their forearms, 7 patients were in their upper arms, and loop shunt was created among 24 patients while straight-shaped shunt was among 8 patients.Treatment results show 2 patients suffered from graft infection due to dialysis puncture in case #1, case #2, infection was due to dehiscence at the graft anastomosis site.In case #1, the gore® acuseal vascular graft was totally replaced with another vascular graft while in case #2, the gore® acuseal vascular graft was partially removed to treat graft infection.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE ACUSEAL VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
craig bearchell
1500 n. 4th street
9285263030
MDR Report Key7934960
MDR Text Key122788389
Report Number2017233-2018-00583
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K130215
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Physician
Type of Report Initial
Report Date 09/10/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received10/04/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age66 YR
-
-